• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Geovax Labs (NQ: GOVX )

    1.839 +0.019 (+1.07%)
    Streaming Delayed Price Updated: 1:02 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Geovax Labs

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Geovax Labs Earnings Preview
    Via Benzinga
    GeoVax to Participate in Upcoming December Investor Events
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    GeoVax to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 8, 2023
    GeoVax to Host Conference Call at 4:30 PM ET 
    Via NewMediaWire
    GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine
    Designed to Protect Immunocompromised Patients Against Severe COVID-19 
    Via NewMediaWire
    Exposures COVID-19
    GeoVax to Participate in Upcoming November Investor and Industry Events
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Earnings Intellectual Property
    Exposures COVID-19 Financial Intellectual Property
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    GeoVax Receives Notice of Allowance for Marburg Vaccine Patent
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property Product Safety
    GeoVax Receives Notice of Allowance for HIV Vaccine Patent
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property
    GeoVax Labs And 3 Other Stocks Under $1 Insiders Are Buying
    The Dow Jones closed lower by around 69 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    GeoVax to Participate in Upcoming October Investor and Industry Events
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX Suspension Cell Line to Bolster MVA-Based Vaccine Development
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    GeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    GeoVax Presents Corporate Update at the H.C. Wainwright 25th Annual Global Investment Conference
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    GeoVax Completes Enrollment of Phase 2 Trial for Next-Generation COVID-19 Vaccine Booster
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19 Product Safety
    GeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    GeoVax to Present at the Emerging Growth Conference on September 6, 2023
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    GeoVax Receives Notice of Allowance for Malaria Vaccine Patent
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Intellectual Property
    Exposures Intellectual Property
    ADDvantage Technologies Group And 3 Other Stocks Under $1 Insiders Are Buying
    The Dow Jones closed slightly lower on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.